(PFE, CLNO) PennyOmega.com Watch List for Monday August 29, 2011
*** The U.S. Food and Drug Administration (FDA) has approved Pfizer's (PFE) XALKORI capsules, the first-ever therapy targeting anaplastic lymphoma kinase (ALK), for the treatment of patients with locally advanced or metastatic non-small cell lung cancer that is ALK-positive as detected by an FDA-approved test.
ABT, ORFG, GRHU, ANNB, BMY, ANIK, - CRWESelect.com Stock News! Abbott Laboratories, Orofino Gold, GreenHouse Holdings, Annapolis
As the world’s foremost imaging innovator, EK helps consumers, businesses, and creative professionals unleash the power of pictures and printing to enrich their lives
EK announced Last January that it filed lawsuits against Apple Inc. and Research In Motion Limited (RIM) alleging the infringement of Kodak digital imaging technology.
(FGP, BMY, AN, PWRM) Market Update From PennyOmega.com
Power3 Medical Products, Inc. (OTC.BB:PWRM) is discovering proteins and protein patterns associated with many diseases including, but not limited to, prostate cancer, breast cancer, Alzheimer's disease, ALS (Lou Gehrig's disease), Parkinson's disease, and gastrointestinal disease.
For shareholders of Pfizer, Inc. (PFE) stock, it has been a pretty barren decade. No investor can look at Pfizer’s ten year chart and miss the fact that the stock has been a multi-year dog. However, from a valuation standpoint, these high-yielding shares are worthy of consideration for patient, income-oriented investors.